DAOA Protein

D-Amino Acid Oxidase (DAO/DAOA) Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | D-Amino Acid Oxidase |
| Gene | DAO/DAOA |
| UniProt ID | O00327 |
| Molecular Weight | ~40 kDa |
| Subcellular Localization | Peroxisomes |
| Protein Family | FAD-dependent oxidoreductases |

</div>

Overview

D-Amino Acid Oxidase (DAO/DAOA) is a flavin adenine dinucleotide (FAD)-dependent enzyme that catalyzes the oxidative deamination of D-amino acids[@pollegioni2007]. It has gained significant attention in neuroscience due to its proposed role in modulating [NMDA receptor](/entities/nmda-receptor) signaling and its genetic association with schizophrenia and other neuropsychiatric disorders.

Structure

DAO contains characteristic structural features essential for its enzymatic function:

• FAD-binding domain: The N-terminal region (approximately 30-200 amino acids) contains the binding site for the flavin adenine dinucleotide cofactor. This domain adopts a characteristic Rossmann-like fold that stabilizes the FAD molecule through hydrogen bonds and hydrophobic interactions[@pawlowski2001].
• Active site: The central region forms the substrate-binding pocket that recognizes the D-stereoisomer of amino acids. The active site contains key catalytic residues including a conserved serine, tyrosine, and glutamate that participate in the oxidative deamination reaction.

D-Amino Acid Oxidase (DAO/DAOA) Protein

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | D-Amino Acid Oxidase |
| Gene | DAO/DAOA |
| UniProt ID | O00327 |
| Molecular Weight | ~40 kDa |
| Subcellular Localization | Peroxisomes |
| Protein Family | FAD-dependent oxidoreductases |

</div>

Overview

D-Amino Acid Oxidase (DAO/DAOA) is a flavin adenine dinucleotide (FAD)-dependent enzyme that catalyzes the oxidative deamination of D-amino acids[@pollegioni2007]. It has gained significant attention in neuroscience due to its proposed role in modulating [NMDA receptor](/entities/nmda-receptor) signaling and its genetic association with schizophrenia and other neuropsychiatric disorders.

Structure

DAO contains characteristic structural features essential for its enzymatic function:

• FAD-binding domain: The N-terminal region (approximately 30-200 amino acids) contains the binding site for the flavin adenine dinucleotide cofactor. This domain adopts a characteristic Rossmann-like fold that stabilizes the FAD molecule through hydrogen bonds and hydrophobic interactions[@pawlowski2001].
• Active site: The central region forms the substrate-binding pocket that recognizes the D-stereoisomer of amino acids. The active site contains key catalytic residues including a conserved serine, tyrosine, and glutamate that participate in the oxidative deamination reaction.
• Peroxisomal targeting signal: The C-terminal region contains the tripeptide SKL (serine-lysine-leucine) peroxisomal targeting signal (PTS1), which directs the enzyme to peroxisomes.
• Dimerization interface: DAO forms functional homodimers, with each monomer capable of independently binding FAD and substrate.

Enzyme Catalysis

Reaction Mechanism

DAO catalyzes the oxidative deamination of D-amino acids:

D-amino acid + O2 + H2O → 2-oxo acid + NH3 + H2O2

The reaction proceeds through a reductive half-reaction where the substrate reduces the flavin, followed by an oxidative half-reaction where the reduced flavin is reoxidized by molecular oxygen, producing hydrogen peroxide as a byproduct.

Substrate Specificity

DAO shows broad specificity for D-amino acids:

• D-serine: Primary physiological substrate in the brain
• D-alanine: Significant substrate in peripheral tissues
• D-aspartate: Important in endocrine tissues
• D-phenylalanine: Metabolized at lower rates

Normal Function

D-Amino Acid Metabolism

DAO plays a crucial role in D-amino acid catabolism:

• D-serine regulation: As the primary catabolic enzyme for D-serine, DAO tightly controls the levels of this important neuromodulator
• Renal metabolism: DAO in kidneys metabolizes D-amino acids from diet and protein turnover
• Liver function: Hepatic DAO processes circulating D-amino acids

Neurotransmission Modulation

In the central nervous system, DAO modulates neurotransmission through:

• D-serine regulation: D-serine is a major NMDA receptor co-agonist, and DAO controls its extracellular levels
• Glutamatergic signaling: By regulating D-serine, DAO indirectly modulates NMDA receptor activity
• Synaptic plasticity: NMDA receptor activation is critical for [long-term potentiation](/mechanisms/long-term-potentiation) and memory formation
• Excitotoxicity: Excessive D-serine may contribute to excitotoxic neuronal damage

Role in Disease

Schizophrenia

DAO/DAOA is one of the most extensively studied schizophrenia risk genes[@lin2014][@rogaeva2007]:

• Genetic association: Multiple genome-wide association studies (GWAS) have identified DAO/DAOA variants as significant risk factors for schizophrenia
• Haplotype structure: Specific haplotypes spanning the DAO gene show association with disease risk
• Expression studies: Post-mortem brain studies reveal altered DAO expression in prefrontal [cortex](/brain-regions/cortex) of schizophrenia patients
• Endophenotypes: DAO variants may influence specific cognitive and neurobiological endophenotypes

Amyotrophic Lateral Sclerosis

• D-serine accumulation: Altered DAO activity may contribute to excitotoxicity in ALS
• Motor neuron vulnerability: May affect susceptibility of motor [neurons](/entities/neurons) to excitotoxic damage

Epilepsy

• Seizure susceptibility: DAO activity may influence seizure threshold
• Therapeutic implications: DAO modulators may have anticonvulsant properties

Therapeutic Implications

DAO Inhibitors

Several DAO inhibitors have been developed as potential therapeutics:

• 4-Phenylbutyric acid (PBA): Weak DAO inhibitor
• Compound 6: Potent DAO inhibitor with central activity
• FAD analogs: Modified flavins that inhibit DAO

D-Serine-Based Approaches

• D-serine supplementation: May benefit patients with impaired DAO function
• Glycine site modulators: Target the NMDA receptor glycine site

Key Publications

Cross-References

• [DAOA Gene](/genes/daoa) — Gene encoding DAO
• [Schizophrenia](/diseases/schizophrenia) — Primary disease association
• [D-Serine](/entities/d-serine) — NMDA receptor co-agonist
• [NMDA Receptor](/mechanisms/nmda-receptor-signaling) — Related mechanism

See Also

• [tau-protein](/proteins/tau) — Related [tau](/proteins/tau) kinase substrate in AD
• [amyloid-beta](/proteins/amyloid-beta-protein) — Related [APP](/entities/app-protein) cleavage product
• [GSK3B](/proteins/gsk3b) — Major kinase in neurodegeneration
• [CDK5](/genes/cdk5) — Another tau kinase
• [BACE1](/entities/bace1) — Beta-secretase in amyloidogenesis

External Links

• [UniProt](https://www.uniprot.org/) - Protein sequence and functional data
• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [PDB](https://www.rcsb.org/) - Protein structure data

References